Contrast-enhanced CT (CECT) can help providers identify high-grade prostate cancers, according to new research published in the American Journal of Roentgenology.

Two days of debate over the safety of paclitaxel-coated and -eluting devices have culminated in a nonbinding recommendation by the FDA to continue sales of such devices for PAD patients, though the agency is also urging regulators to push for better long-term clinical data than is currently available.

The Financial Times of London is calling for caution—along with standardized and modernized regulation—around AI in healthcare.

AI in healthcare and wearables are buzzy words in the sector, but not all patients are on board with injecting biometric monitoring devices (BMDs) into their daily lives. And that non-acceptance could prove problematic for the future of these devices and other AI-based tools, according to a recent study from French researchers with Université Paris Descartes.

The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular Therapeutics conference, the groups announced June 20.

Health officials south of the border may soon be able to fight a nasty disease using just their smartphones and an AI tool for reverse image searches.

Natural language processing (NLP) can provide significant value by auditing all communications related to critical findings, according to a new study published in the Journal of the American College of Radiology.

Repealing the Affordable Care Act would have serious, immediate consequences, according to the Urban Institute, including 20 million more uninsured people.

Royal Philips has rolled out the latest update for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems, expanding to include automated applications for 2D assessment of the heart and robust 3D measurements of right ventricular volume and ejection fraction.

President Trump is planning to issue an executive order that will “compel the disclosure” of healthcare prices, according to The Wall Street Journal, which cited people familiar with the matter.